Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report

Patients with urologic chronic pelvic pain syndromes (UCPPS) report interstitial cystitis/bladder pain syndrome and/or chronic prostatitis/chronic pelvic pain syndrome. The pathogenesis of these syndromes remains unclear and there is currently no standard treatment. UCPPS is, therefore, often misdia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Bo, Shan, Liping, Zhou, Die
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810449/
https://www.ncbi.nlm.nih.gov/pubmed/29397676
http://dx.doi.org/10.9758/cpn.2018.16.1.122
_version_ 1783299756856967168
author Bi, Bo
Shan, Liping
Zhou, Die
author_facet Bi, Bo
Shan, Liping
Zhou, Die
author_sort Bi, Bo
collection PubMed
description Patients with urologic chronic pelvic pain syndromes (UCPPS) report interstitial cystitis/bladder pain syndrome and/or chronic prostatitis/chronic pelvic pain syndrome. The pathogenesis of these syndromes remains unclear and there is currently no standard treatment. UCPPS is, therefore, often misdiagnosed and its management is complex. The present case report involves a 62-year-old male patient with UCPPS whose main presentation is painful bladder filling and painful urgency refractory to conventional treatment with medication, which was successfully treated with the combined use of duloxetine and olanzapine. The combined use of duloxetine and olanzapine may become a new therapeutic option in the management of UCPPS.
format Online
Article
Text
id pubmed-5810449
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-58104492018-02-21 Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report Bi, Bo Shan, Liping Zhou, Die Clin Psychopharmacol Neurosci Case Report Patients with urologic chronic pelvic pain syndromes (UCPPS) report interstitial cystitis/bladder pain syndrome and/or chronic prostatitis/chronic pelvic pain syndrome. The pathogenesis of these syndromes remains unclear and there is currently no standard treatment. UCPPS is, therefore, often misdiagnosed and its management is complex. The present case report involves a 62-year-old male patient with UCPPS whose main presentation is painful bladder filling and painful urgency refractory to conventional treatment with medication, which was successfully treated with the combined use of duloxetine and olanzapine. The combined use of duloxetine and olanzapine may become a new therapeutic option in the management of UCPPS. Korean College of Neuropsychopharmacology 2018-02 2018-02-28 /pmc/articles/PMC5810449/ /pubmed/29397676 http://dx.doi.org/10.9758/cpn.2018.16.1.122 Text en Copyright © 2018, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Bi, Bo
Shan, Liping
Zhou, Die
Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report
title Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report
title_full Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report
title_fullStr Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report
title_full_unstemmed Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report
title_short Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report
title_sort combined use of duloxetine and olanzapine in the treatment of urologic chronic pelvic pain syndromes refractory to conventional treatment: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810449/
https://www.ncbi.nlm.nih.gov/pubmed/29397676
http://dx.doi.org/10.9758/cpn.2018.16.1.122
work_keys_str_mv AT bibo combineduseofduloxetineandolanzapineinthetreatmentofurologicchronicpelvicpainsyndromesrefractorytoconventionaltreatmentacasereport
AT shanliping combineduseofduloxetineandolanzapineinthetreatmentofurologicchronicpelvicpainsyndromesrefractorytoconventionaltreatmentacasereport
AT zhoudie combineduseofduloxetineandolanzapineinthetreatmentofurologicchronicpelvicpainsyndromesrefractorytoconventionaltreatmentacasereport

Ejemplares similares